Eminent neurosurgeon in private sector collaborates with public sector counterpart to build super speciality surgical skills
Drickus Maartens • December 11, 2019
Above: Neurosurgeon, Dr Pieter Slabbert (left) from Netcare Pretoria East Hospital, is pictured with Dr Nomusa Shezi (centre), a neurosurgeon at Inkosi Albert Luthuli Central Hospital (IALCH), and IALCH registrar, Dr Mduduzi Msomi (right) during a public-private training initiative for deep brain stimulation (DBS) procedures at the Durban public hospital. The training was made possible by Netcare and medical technology company Medtronic. Dr Slabbert is one of the most experienced neurosurgeons in the complicated techniques involved in DBS procedures, used for the treatment of various movement disorders including Parkinson’s disease.
Eminent neurosurgeon in private sector collaborates with public sector counterpart to build super speciality surgical skills
Collaboration between the private and public health sectors recently created an opportunity for the sharing of super specialised medical expertise, when eminent neurosurgeon, Dr Pieter Slabbert who practises at Netcare Pretoria East Hospital, and his counterpart neurosurgeon, Dr Nomusa Shezi from Inkosi Albert Luthuli Central Hospital, performed two highly complex brain surgery procedures at the public sector hospital in Durban.
“Dr Slabbert is one of the most experienced neurosurgeons in the complicated techniques involved in deep brain stimulation [DBS] procedures, used for the treatment of various movement disorders. He has frequently assisted visiting neurosurgeons from around the world to hone their skills required for this super specialised procedure,” says Dr Erich Bock, Netcare’s North East regional director.
Dr Shezi, who achieved a remarkable feat by becoming KZN’s first black female African neurosurgeon in 2017 and is in the process of developing a Functional Neurosurgery unit in her Department, previously visited Netcare Pretoria East Hospital in order to observe Dr Slabbert perform the DBS procedure. The 34-year-old neurosurgeon then asked Dr Slabbert, who is one of only a handful of neurosurgeons in South Africa versed in this super speciality, to mentor her in the technique, which will ultimately benefit many public sector patients suffering from nervous system disorders that severely affect their movement, such as dystonia and Parkinson’s disease.
“Parkinson’s disease is not a terminal illness, however over time this progressive condition erodes the individual’s quality of life to the point where they often lose their independence. Eventually, people with Parkinson’s may lose the ability to drive, dress themselves and may have difficulty completing other daily tasks because the condition causes tremors and slows movement,” Dr Slabbert explains.
The DBS procedure involves implanting electrodes deep in the brain, which are connected with thin leads to a neurostimulator device implanted in the patient’s chest. Once the device is turned on, the stimulation effect can dramatically reduce symptoms, resulting in the person’s quality of life being greatly restored.
“In conjunction with medication, DBS has shown excellent results with improvements of up to 90% in the management of symptoms associated with movement disorders,” notes Dr Slabbert, who has performed over 400 such procedures.
In a public-private training initiative, made possible by Netcare and medical technology company Medtronic, the manufacturer of the DBS device, Dr Slabbert and his experienced team including specialised nursing professionals from Netcare Pretoria East Hospital travelled to Inkosi Albert Luthuli Central Hospital in order to perform onsite training while two DBS procedures were performed by the neurosurgeons.
“The opportunity to learn from such an experienced neurosurgeon as Dr Slabbert, who is internationally respected in this highly specialised field, and his team has been an enriching experience. We have not only gained expertise from this exercise, but also developed the skill to perform this intricate brain surgery. We are grateful to Dr Slabbert and his team, as well as to Netcare and Medtronic for making this collaboration possible,” Dr Shezi says.
Dr Shezi is currently developing Functional neurosurgery expertise within the public sector and, working with her team including specialist neurologist, Dr Ferzana Amod, is establishing a movement disorder unit at Inkosi Albert Luthuli Central Hospital to assist more public sector patients with movement disorders such as Parkinson’s disease.
“To see the difference DBS has made in the lives of patients and their families is truly rewarding. We will be applying the skills learned to benefit more of our patients in KwaZulu-Natal and further afield in the future, and this will also allow us the opportunity to add to the scientific body through research,” Dr Shezi adds.
Dr Slabbert urges other specialists in the private sector to partner with their counterparts in the public sector to help build expertise and capacity in their respective fields. “As a medical community we need to invest time in our colleagues, so that we are all empowered with the necessary expertise to deliver world-class treatments to more patients,” he concluded.
Migraines affect 15% of the global population, causing severe pain and disrupting daily life. Neurologist Dr. Michael Huth emphasises the importance of understanding different migraine types and their triggers.
Dr Michael de Villiers explains why people can become sick every flu season and why the influenza vaccine is generally recommended every year.
Colorectal cancer, one of the most prevalent yet preventable cancers, can develop in the colon or rectum, often starting as small polyps that can quietly become malignant if left unchecked. Dr Mpho Ramabulana, a colorectal surgeon and gastroenterologist at Netcare Akasia Hospital, underscores the life-saving power of vigilance and the importance of early detection.
Cardiologist Dr Robert Routier urges the public to check their personal risk factors regularly to help prevent or manage cardiovascular disease.
The physical strain pregnancy puts on an expectant mother’s body should not be underestimated. An obstetrician gynaecologist offers her insights for alleviating discomfort and promoting wellbeing with exercise and stretching throughout pregnancy.
Dr Patience Sigwadi, a leading paediatric nephrologist practising at Netcare Unitas Hospital in Centurion, has issued an urgent call for increased focus on skills development to address the escalating kidney disease crisis among children in South Africa.
Paediatric Nephrologist Professor Bhimma was recently awarded the Fellowship to acknowledge his extensive work in research, community-based outreach and teaching of paediatric nephrology, among others.
Netcare congratulates Professor Bhekifa Dube on his invitation to join the European Society for Vascular Surgery's clinical practice guidelines committee. His selection as the only specialist from the continent highlights the significance of this achievement on the global stage.
The lives of millions of South Africans with a litany of rare diseases can be vastly improved, and even saved, by addressing challenges in identifying, studying and treating their conditions. With Rare Disease Day on the 28th of February 2025, the Rare Diseases Access Initiative (RDAI) is driving an evolution of the country’s healthcare, through innovative strategies to better care for over 4.2million people living with an estimated 7000 rare diseases. “As our healthcare system faces significant changes in the years ahead, it is vital that we also advocate for people living with rare diseases in South Africa, especially those with limited healthcare access,” said Kelly du Plessis, CEO of Rare Diseases South Africa (RDSA), a member of RDAI. “As part of our ongoing research and awareness efforts, RDAI has conducted an initial analysis of the incidence and prevalence of rare diseases within the country.” This research will assist in improving access to healthcare, policy development, and patient advocacy, while giving critical insight into the challenges faced by patients. “According to research, some rare diseases affect fewer than 1 in a million people, while others, such as Down syndrome, cystic fibrosis, and haemophilia, have a more recognisable prevalence,” says Dr. Helen Malherbe, RDAI lead researcher on rare disease prevalence data. “Many conditions are undetected, underdiagnosed or misdiagnosed, with too many having no information available about them at all.” The RDAI was formed in 2019 to promote a more favourable environment for those impacted by rare diseases in South Africa. Participants include Ampath, the Board of Healthcare Funders (BHF), Discovery Health, Genetic Counsellors South Africa (SASHG), the Government Employees Medical Scheme (GEMS), Health Funders Association (HFA), Medihelp, Medscheme, North-West University (NWU), Rare Diseases South Africa (RDSA), the South African Medical Association (SAMA) and The South African Medical Technology Industry Association (SAMED). The Council for Medical Schemes (CMS) participates as an observer. In the same year, Rare Disease International signed a memorandum of understanding with the World Health Organisation leading to an international rare disease policy framework. In 2021, the United Nations General Assembly moved to adopt a resolution recognising 300 million people living with rare diseases worldwide. “A general lack of awareness and delayed diagnosis remain major hurdles for those affected by rare diseases. Policymakers and healthcare stakeholders need to prioritise access to treatment, diagnosis, and support for rare disease patients,” says Bada Pharasi, CEO of IPASA, “Through this initiative, working collaboratively with stakeholders at every level of the healthcare supply chain, we can bring real and meaningful change to those affected, including family members and care givers, through smart and efficient strategies.” The globally agreed definition of a rare disease is any medical condition with a specific pattern of clinical signs, symptoms, and findings that affects fewer than or equal to 1 in 2000 persons in a population. “Most are genetic, and some are inherited and passed down in families,” Malherbe says. “Some affect only the patient’s genetic recipe, while others may be acquired during life due to infection, trauma, or environmental effects. For many, the cause is still unknown. “These conditions mainly affect children, as they are largely incurable and many are life-threatening. Some require specialised and co-ordinated care, some have limited and expensive treatment options, while others have no information or effective treatments at all,” she adds. The RDAI is calling for a patient-centred care model built on equitable access, transparency and efficiency. Naturally, this model calls for the open participation of patients, the healthcare industry, health professionals, and the Government. “The most critical elements are robust diagnosis standards, improved access to treatment, data collection and management, co-ordination of care, measurement of outcomes and ongoing collaborative research,” du Plessis says. “We need to establish rare disease advisory committees, map gaps and opportunities, establish system requirements, create a roadmap and plan a phased implementation with clear timelines.” The RDAI states that these policy development steps would be a start in quantifying the disease burden and defining standards of care. This would be followed by building and strengthening the capacity to facilitate appropriate diagnosis, treatment, continuity and data monitoring. Thoneshan Naidoo, Chief Executive Officer of the Health Funders Association noted that, “We appreciate the unique opportunity provided by RDAI which enables stakeholders across the industry to work together and identify strategies that improve equitable access to the appropriate diagnosis, treatment and healthcare services for rare disease patients, in an affordable and sustainable manner, taking account of the other pressing needs across the healthcare system.” “True innovation in healthcare is only possible through partnerships and joint advocacy efforts that raise awareness and improve access to treatment. Our long-term goal is the development of a rare diseases policy framework and guidelines for coordinated care,” says Pharasi. “Our members are united in the commitment to unlocking improved patient outcomes and improving access to services and robust health needs assessment facilities.” he concludes. About RDAI The Rare Diseases Access Initiative (RDAI) is dedicated to advocating for improved healthcare access, policy development, and patient support for those affected by rare diseases in South Africa. The initiative brings together key healthcare stakeholders, including pharmaceutical associations, funders, genetic specialists, and patient advocacy groups, to drive impactful change. About RDSA Founded in 2013, Rare Diseases South Africa (RDSA) is a non-profit organisation advocating to ensure that people living with rare diseases and congenital disorders experience greater recognition, support, improved health service and better overall quality of life. Started out of personal need following the diagnosis of organisation founder, Kelly du Plessis' son, it became evident that there was a lack of awareness and support for rare diseases in general in South Africa. About IPASA The Innovative Pharmaceutical Association South Africa (IPASA) is a voluntary trade association representing 24 leading pharmaceutical companies committed to research, development, and innovation. Our mission is to drive healthcare advancement by advocating for policies that improve patient access to safe, high-quality, and affordable medicines.
Gastroenterologist Dr. Barbara Makumbi discusses common risk factors and offers tips for managing reflux and the longer-term condition known as gastroesophageal reflux disease (GORD).
